BioGaia AB (publ)
BioGaia AB (publ) (BIOGY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOGY · as of Jun 8, 2026
Key Statistics
Explore BioGaia AB (publ) Data
biogy stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
biogy competitorsBIOGY
EVOTF
GNMLF
KSPHF
LJUIF
PBHDFStock Performance
Full HistoryAbout BioGaia AB (publ)
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics seg…
what is biogaia ab (publ) · biogy stock overview · biogaia ab (publ) company profile · who is biogaia ab (publ) ceo · biogy OTC · biogaia ab (publ) headquarters · biogaia ab (publ) business segments
About Stock Overview & Key Data
BioGaia AB (publ) (BIOGY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 8, 2021. As of the latest trading session, BIOGY stock price is $11.00, with a market capitalization of $1.1B. The stock has returned +22.49% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, BioGaia AB (publ) reported revenue of $1.5B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioGaia AB (publ) (BIOGY) stock price is $11.00. The stock is traded on OTC under the ticker symbol BIOGY. The 52-week range is $8.79 – $11.46.